INTRODUCTION
============

Ca^2+^ channels allow most electrical and many chemical signals to be transduced into the changes in cytosolic Ca^2+^ concentration that regulate almost every aspect of cellular activity \[[@B1]\]. Most Ca^2+^ channels are also regulated by Ca^2+^, either directly or via CaM (calmodulin) \[[@B2]\]. This provides feedback regulation of Ca^2+^ signalling and it allows Ca^2+^ channels to evoke regenerative Ca^2+^ signals \[[@B3]\]. The latter are important because they underpin the versatility of Ca^2+^ as an intracellular messenger, permitting it to function either locally or globally \[[@B1]\].

Two major families of intracellular Ca^2+^ channels, IP~3~Rs \[IP~3~ (inositol 1,4,5-trisphosphate) receptors\] and RyRs (ryanodine receptors), share many structural \[[@B4],[@B5]\] and functional \[[@B5]--[@B7]\] properties. Most notably, all IP~3~Rs and RyRs are stimulated by low concentrations of cytosolic Ca^2+^ and inhibited by higher concentrations. Ca^2+^-binding sites within the RyR itself can mediate this biphasic Ca^2+^ regulation \[[@B7]\], but, for IP~3~Rs, it remains unclear whether additional Ca^2+^-binding proteins are required \[[@B6]\]. None of the many Ca^2+^-binding sites in RyRs \[[@B8]\] or IP~3~Rs \[[@B9]\] has been unambiguously associated with Ca^2+^ regulation of channel gating \[[@B10],[@B11]\], although mutation of a single equivalent residue in RyRs or IP~3~Rs (Glu^2100^ in IP~3~R1) modulates their Ca^2+^-sensitivity \[[@B11]\]. Both families of intracellular Ca^2+^ channels are also regulated by CaM, a ubiquitously expressed and highly conserved Ca^2+^-binding protein \[[@B12]\]. Related proteins with EF-hand Ca^2+^-binding structures, such as S100A and CaBP1 (Ca^2+^-binding protein 1), also regulate RyRs and IP~3~Rs, but the physiological significance of these interactions between intracellular Ca^2+^ channels and CaM or related proteins is unresolved \[[@B13],[@B14]\]. Despite some conflicting evidence \[[@B15]\], CaM seems not to be essential for Ca^2+^ regulation of RyRs or IP~3~Rs \[[@B16]--[@B18]\], but it does regulate both channels and it modulates their responses to Ca^2+^ \[[@B19]--[@B21]\].

All IP~3~Rs are inhibited by Ca^2+^--CaM \[[@B22]\], but neither of the two CaM-binding sites within IP~3~R1, nor a third that is created by alternative splicing \[[@B23]\], clearly mediates this inhibition of IP~3~-evoked Ca^2+^ release. The central site \[[@B24]\] ([Figure 1](#F1){ref-type="fig"}A) mediates neither Ca^2+^ nor CaM regulation of IP~3~R activity \[[@B16],[@B17]\] and it is absent from IP~3~R3. The functional role of the split N-terminal site ([Figure 1](#F1){ref-type="fig"}A), one component of which may also bind CaBP1 \[[@B25]\], is also unclear. It has been proposed to bind CaM and thereby to inhibit IP~3~R activity, but only when Ca^2+^ has bound elsewhere \[[@B26]\]. The evidence that CaM inhibits IP~3~R only in the presence of Ca^2+^, without CaM itself providing the Ca^2+^-sensor, is persuasive \[[@B26]\], but there is no compelling evidence to link this to the N-terminal CaM-binding site \[[@B27]\].

![A putative 1-8-14 motif within the SD of the IP~3~R\
(**A**) Key features of a rat IP~3~R showing the NT, with its component parts (SD and IBC), the six C-terminal transmembrane domains (TMD) that form the pore and the CaM-binding domains (yellow). Residue numbers are shown. (**B**) Comparison of 1-8-14 motifs showing the conserved hydrophobic residues of the consensus sequence in blue. Charged residues within the 1-8-14 motif are highlighted in red because the consensus motif has a net charge of +3 to +6. The lower panel shows the peptides used with mutated residues underlined. (**C**) Structure of the SD of IP~3~R1 (PDB code 1XZZ) and the equivalent region (A domain) of RyR1 (PDB code 3HSM) with the pseudo-1-8-14 motif highlighted and compared with MLCK in the structure it adopts when bound to Ca^2+^--CaM (PDB code 1QTX).](bj2012-1034i001){#F1}

The links between CaM binding and function are better understood for RyRs, although the effects differ between RyR subtypes \[[@B7]\]. A single site on each RyR1 subunit (residues 3614--3643 in rabbit RyR1), which is conserved in all RyRs, binds the C-terminal lobe of both apo-CaM and Ca^2+^--CaM and appears to mediate the functional effects of CaM \[[@B20],[@B28],[@B29]\]. As this tethered CaM binds Ca^2+^, it migrates towards the NT (N-terminus) of the binding site and the CaM switches from activating RyR1 to inhibiting it \[[@B19]\]. The CaM-binding site of RyR1 also engages other CaM-like domains, notably the C-terminus of the L-type Ca^2+^ channel which inhibits RyR1 activity \[[@B30]\], and perhaps an EF-hand-like structure within the C-terminal region of RyR1 which binds Ca^2+^ and modulates Ca^2+^ regulation of RyR \[[@B31]\]. These observations suggest that the CaM-binding domain of RyR also mediates important inter- and intra-molecular interactions, and that the complex effects of CaM and related proteins may, at least in part, result from disrupting these interactions \[[@B29],[@B31],[@B32]\].

For IP~3~Rs, IP~3~ binding to the IBC (IP~3~-binding core) (residues 224--604) ([Figure 1](#F1){ref-type="fig"}A) initiates the conformational changes that lead to opening of a pore formed by the C-terminal transmembrane domains of each of the four IP~3~R subunits \[[@B5],[@B33]\]. These conformational changes pass via the N-terminal SD (suppressor domain) (residues 1--223), which is essential for IP~3~R activation. Indeed, the major conformational changes associated with IP~3~R activation appear to occur within the NT (residues 1--604) \[[@B5],[@B33]\]. Although both IP~3~ and Ca^2+^ are required for IP~3~R activation \[[@B6],[@B34]\], it is not yet clear how the conformational changes initiated by IP~3~ lead to Ca^2+^ binding and then to gating of the pore. It is therefore intriguing that a CaM-binding peptide derived from MLCK (myosin light chain kinase), which comprises a 1-8-14 CaM-binding sequence \[[@B35]\], reversibly inhibits IP~3~-evoked Ca^2+^ release \[[@B36]\] via all three vertebrate IP~3~R subtypes. Furthermore, MLCK peptide is more potent in the presence of Ca^2+^ \[[@B35]\]. This inhibition is entirely independent of CaM and involves interaction of MLCK peptide with the NT in a manner that requires the SD \[[@B35]\]. We speculate, by analogy with RyRs, that inhibition of IP~3~Rs by MLCK peptide might result from disruption of an interaction between endogenous CaM-like and CaM-binding domains within IP~3~Rs, and that, for IP~3~Rs, this interaction is essential for activation. In the present study, we explored this hypothesis further.

EXPERIMENTAL
============

Materials
---------

Cell culture materials were from Gibco, except for fetal bovine serum (Sigma). CaM purified from bovine brain was from Calbiochem. \[^3^H\]IP~3~ (18 Ci/mmol) was from PerkinElmer. IP~3~ was from Alexis Biochemicals. Peptides were synthesized and purified by Sigma or New England Peptide, and each was shown to be \>90% pure by HPLC. The peptide sequences are listed in Supplementary Table S1 (at <http://www.BiochemJ.org/bj/449/bj4490039add.htm>).

Site-directed mutagenesis
-------------------------

The NT (residues 1--604) and IBC (residues 224--604) of rat IP~3~R1 were amplified by PCR from the full-length receptor clone lacking the SI splice region (GenBank® accession number GQ233032.1) as described previously \[[@B33]\]. The fragments were ligated into pTrcHis A (Invitrogen) to allow expression of N-terminally His~6~-tagged proteins. Mutagenesis of the 1-8-14 motif within the NT used the QuikChange® II XL site-directed mutagenesis kit (Stratagene) for single mutants (F53E, L60E, Y66E and K52E) and the QuikChange® multi-site-directed mutagenesis kit for the double mutant (F53E and Y66E). The primers used are listed in Supplementary Table S2 (at <http://www.BiochemJ.org/bj/449/bj4490039add.htm>). The same primers and conditions were used for mutagenesis of full-length IP~3~R using IP~3~R1 in the pENTR 1A vector. Full-length constructs were subcloned into pcDNA3.2/V5-DEST for expression in DT40 cells. The complete sequence of every mutant construct was verified by sequencing.

Culture and stable transfection of DT40 cells
---------------------------------------------

DT40 cells in which the genes for all three IP~3~R subtypes had been disrupted (DT40-KO) \[[@B37]\] and DT40 cells stably expressing rat IP~3~R1 (DT40-IP~3~R1) were grown in RPMI 1640 medium supplemented with 10% (v/v) fetal bovine serum, 1% (v/v) heat-inactivated chicken serum, 2 mM [l]{.smallcaps}-glutamine and 50 μM 2-mercaptoethanol. Cells were grown in suspension in 175 cm^2^ flasks at 37°C in an atmosphere of 5% CO~2~. They were used or passaged when they reached a density of \~2×10^6^ cells/ml. To generate stable cell lines expressing mutant IP~3~R, the mutant construct in pcDNA3.2/V5-DEST was linearized, and DT40 cells were transfected by nucleofection (Amaxa, protocol B-23). Cell lines were selected with G-418 (2 mg/ml) and screened initially by Western blotting using a peptide antiserum to IP~3~R1 \[[@B38]\] as described previously \[[@B33]\], and then using the functional assay described below.

Ca^2+^ release from the intracellular stores of permeabilized cells
-------------------------------------------------------------------

The free Ca^2+^ concentration of the intracellular stores of permeabilized cells was measured using a low-affinity Ca^2+^ indicator trapped within the endoplasmic reticulum as reported previously \[[@B39]\]. Briefly, DT40 cells (4×10^7^ cells/ml) were suspended in HBS (Hepes-buffered saline: 135 mM NaCl, 5.9 mM KCl, 11.6 mM Hepes, 1.5 mM CaCl~2~, 11.5 mM glucose and 1.2 mM MgCl~2~, pH 7.3) containing 1 mg/ml BSA, 0.4 mg/ml Pluronic F127 and 20 μM mag-fluo-4/AM (Invitrogen). After 1 h at 20°C in the dark with gentle shaking, cells were centrifuged at 650 ***g*** for 2 min and resuspended to 10^7^ cells/ml in Ca^2+^-free CLM (cytosol-like medium) (20 mM NaCl, 140 mM KCl, 1 mM EGTA, 20 mM Pipes and 2 mM MgCl~2~, pH 7.0) containing 20 μg/ml saponin. After incubation at 37°C with gentle shaking for 4 min, permeabilized cells were centrifuged at 650 ***g*** for 2 min and resuspended in Mg^2+^-free CLM, supplemented with CaCl~2~ to give a final free Ca^2+^ concentration of 220 nM. The free Ca^2+^ concentration of CLM was calculated using the MaxChelator program (<http://maxchelator.stanford.edu>) and then measured using fluo-3 or fura-2. Cells were then washed, resuspended in Mg^2+^-free CLM containing 10 μM FCCP (carbonyl cyanide *p*-trifluoromethoxyphenylhydrazone) to inhibit mitochondria, and distributed into a 96-well plate (10^6^ cells in 50 μl of CLM/well). After centrifugation, fluorescence from the luminal indicator was recorded using a FlexStation II platereader (Molecular Devices) equipped to allow automated additions \[[@B39]\]. In all experiments, the intracellular stores were allowed to load to steady-state with Ca^2+^ after addition of MgATP. IP~3~ was then added with thapsigargin (1 μM, to inhibit Ca^2+^ reuptake). The Ca^2+^ release evoked by IP~3~ is expressed as a fraction of the ATP-dependent Ca^2+^ uptake.

Patch-clamp recording
---------------------

Currents were recorded from patches excised from the outer nuclear envelope of DT40 cells expressing recombinant rat IP~3~R1 using symmetrical caesium methanesulfonate (140 mM) as the charge-carrier. The composition of recording solutions and methods of analysis were otherwise as described previously \[[@B40]\].

Expression of N-terminal fragments of IP~3~R
--------------------------------------------

The pTrcHis constructs were used for expression of N-terminally His~6~-tagged proteins in *Escherichia coli* strain BL21(DE3) cells. Before use for \[^3^H\]IP~3~ binding, proteins were cleaved from the His~6~ tags using biotinylated thrombin (Novagen) at the engineered thrombin-cleavage site \[[@B33]\]. Complete cleavage was verified by Western blotting using an anti-His~6~ antibody. The proteins were used for \[^3^H\]IP~3~ binding without further purification \[[@B33]\].

\[^3^H\]IP~3~ binding
---------------------

Equilibrium-competition binding assays were performed at 4°C for 5 min in CLM (500 μl) with a free Ca^2+^ concentration of 220 nM and containing \[^3^H\]IP~3~ (0.75--1.5 nM), bacterial lysate (10 μg of protein for IBC and 100 μg of protein for NT) or cerebellar membranes (50 μg of protein) and competing ligands. Non-specific binding was defined by addition of 10 μM IP~3~. Bound and free \[^3^H\]IP~3~ were separated by centrifugation at 20000 ***g*** for 5 min, after addition of poly(ethylene glycol) (15% final concentration) and γ-globulin (0.75 mg) for soluble proteins. Results were analysed by fitting to a Hill equation (using GraphPad Prism) from which the IC~50~ (half-maximal inhibitory concentration) and thereby the *K*~d~ (equilibrium dissociation constant) were calculated \[[@B33]\].

Western blotting
----------------

Cells in Ca^2+^-free CLM containing 2-mercaptoethanol (1 mM) and protease inhibitors were lysed by addition of PopCulture (10%), lysozyme (10 μg/ml), DNAse (5 units/ml) and RNAse (10 μg/ml). The proteins were separated using SDS/PAGE pre-cast mini-gels (Invitrogen) and transferred on to a PVDF membrane using an Iblot dry-transfer apparatus (Invitrogen). The primary antibodies were rabbit anti-His~6~ (1:3000 dilution) (Sigma) and anti-IP~3~R1 (1:1000 dilution) \[[@B33]\]. HRP (horseradish peroxidase)-conjugated anti-rabbit secondary antibodies (1:5000 dilution) (AbCam) and the Super Signal West Pico chemiluminescence reagent (Pierce) were used to detect immunoreactivity. Bands were quantified using GeneTools software (Syngene).

Statistical analysis
--------------------

For comparisons of *K*~d~, EC~50~ (half-maximally effective concentration) or IC~50~ values, their negative logarithms (p*K*~d~, pEC~50~ and pIC~50~; means±S.E.M.) were used for statistical analyses. For clarity, some Figures show normalized results, but all statistical analyses were performed on the raw data using paired or unpaired Student\'s *t* tests. *P*\<0.05 was considered significant.

RESULTS AND DISCUSSION
======================

Reversible inhibition of IP~3~-evoked Ca^2+^ release by an endogenous 1-8-14 peptide
------------------------------------------------------------------------------------

A sequence within the SD of all known IP~3~Rs (residues 53--66 in rat IP~3~R1; Supplementary Figure S1 at <http://www.BiochemJ.org/bj/449/bj4490039add.htm>) includes the critical hydrophobic residues of a 1-8-14 CaM-binding motif appropriately oriented within the known structure of the SD \[[@B41]\] ([Figures 1](#F1){ref-type="fig"}B and [1](#F1){ref-type="fig"}C) and with the required net positive charge \[[@B35]\]. The sequence lies within one of the two regions (residues 49--81; [Figure 1](#F1){ref-type="fig"}A) within the NT reported to bind CaM \[[@B42]\] and CaBP1 \[[@B14]\]. A similar sequence is present within the N-terminal of all RyRs (Supplementary Figure S1). To test our hypothesis that inhibition of IP~3~R by MLCK peptide results from disruption of an essential interaction involving an endogenous 1-8-14 motif, we assessed the effects of a peptide derived from this motif (1-8-14 peptide; [Figure 1](#F1){ref-type="fig"}B and Supplementary Table S1) on IP~3~-evoked Ca^2+^ release.

The 1-8-14 peptide inhibited IP~3~-evoked Ca^2+^ release via IP~3~R1 without affecting either Ca^2+^ uptake or the sensitivity (EC~50~) to IP~3~ ([Figures 2](#F2){ref-type="fig"}A--[2](#F2){ref-type="fig"}D). A maximally effective concentration of the peptide reduced the maximal response to IP~3~ by 77±7%. The IC~50~ for 1-8-14 peptide was 767 μM (pIC~50~, 3.1±0.25) ([Figure 2](#F2){ref-type="fig"}C). Neither a mutant 1-8-14 peptide, in which two critical hydrophobic residues are mutated (1-8-14^C^, 3 mM) nor a scrambled peptide (1-8-14^S^, 3 mM) had any effect on IP~3~-evoked Ca^2+^ release ([Figure 2](#F2){ref-type="fig"}C). Both MLCK peptide (isoelectric point, pI 14.0) and 1-8-14 peptide (pI 11.6) are very basic and might therefore have inhibited IP~3~-evoked Ca^2+^ release by binding directly to IP~3~. We demonstrated previously that this was not the case for MLCK peptide \[[@B35]\], and it is also unlikely for the 1-8-14 peptide. The 1-8-14 and 1-8-14^S^ peptides are equally basic, but only the former inhibited IP~3~R; the percentage inhibition caused by 3 mM 1-8-14 peptide is similar for all IP~3~ concentrations (\~75%), and neither was the inhibition reduced by increasing the IP~3~ concentration beyond that required to stimulate maximal Ca^2+^ release ([Figure 2](#F2){ref-type="fig"}B). We conclude that 1-8-14 peptide inhibits IP~3~-evoked Ca^2+^ release by binding to IP~3~R.

![Inhibition of IP~3~R by 1-8-14 peptide\
(**A**) Typical recording of the free Ca^2+^ concentration within the endoplasmic reticulum of a population of permeabilized DT40-IP~3~R1 cells showing Ca^2+^ uptake after addition of MgATP (1.5 mM), release of Ca^2+^ after addition of IP~3~ (10 μM, with 1 μM thapsigargin to inhibit Ca^2+^ re-uptake) and inhibition of that release by 1-8-14 peptide (3 mM, present throughout as indicated, upper trace). Results are means±S.E.M. for three replicates from a single experiment. (**B**) Concentration-dependent release of intracellular Ca^2+^ stores by IP~3~ alone or after pre-incubation for 2.5 min with 1-8-14 peptide (3 mM). Inhibition by 1-8-14 peptide at each IP~3~ concentration is also shown (%). 1-8-14 peptide caused a significant decrease in the maximal response (*P*\<0.001) without significantly changing the sensitivity to IP~3~. (**C** and **D**) Permeabilized cells pre-incubated for 10--20 min with the indicated concentrations of peptide were stimulated with IP~3~ (10 μM, in the continued presence of peptide). Results show the Ca^2+^ content of the stores before addition of IP~3~, and the Ca^2+^ release evoked by IP~3~. (**E**) Permeabilized cells were incubated alone or with 1-8-14 peptide (3 mM) for 10--20 min, washed and then resuspended in CLM. Ca^2+^ release by IP~3~ (10 μM) was then measured after a further incubation for 10--20 min with the indicated concentrations of 1-8-14 peptide. The Ca^2+^ release evoked by IP~3~ with and without peptide is shown for naive cells and after the pre-treatment with 3 mM peptide. The results establish that the effects of 1-8-14 peptide are fully reversible. (**F**) Permeabilized cells pre-incubated with or without 1-8-14 peptide (1 mM) for 10--20 min were stimulated with a maximally effective concentration of IP~3~ in the continued presence of peptide in CLM with the indicated free Ca^2+^ concentration. Results show the inhibition of IP~3~-evoked Ca^2+^ release (%) by 1-8-14 peptide at each free Ca^2+^ concentration. Results in (**B**)--(**F**) are means±S.E.M. (*n*≥3). *\*P*\<0.05, *\*\*P*\<0.01 and *\*\*\*P*\<0.001.](bj2012-1034i002){#F2}

The 1-8-14 peptide is only 16 residues long. A longer peptide (30 residues, 1-8-14^L^), which includes additional N- and C-terminal residues that are conserved in all IP~3~Rs ([Figure 1](#F1){ref-type="fig"}B and Supplementary Figure S1), also inhibited IP~3~-evoked Ca^2+^ release without affecting Ca^2+^ uptake ([Figure 2](#F2){ref-type="fig"}D). Although IP~3~R may be slightly more sensitive to the longer peptide (IC~50~, 326 μM; pIC~50~, 3.5±0.25) than to the 1-8-14 peptide (767 μM, 3.1±0.25); the difference was not statistically significant. Subsequent studies used the shorter 1-8-14 peptide because it was less expensive.

The results shown in [Figure 2](#F2){ref-type="fig"}(E) demonstrate that the effects of a maximally effective concentration of 1-8-14 peptide (3 mM) are fully reversible. These experiments, which require extensive washing of the cells between successive challenges with the peptide, confirm that the inhibition of IP~3~Rs by the 1-8-14 peptide, like that by MLCK peptide \[[@B35]\], does not result from dissociation of CaM from IP~3~R \[[@B36]\]. Our previous study demonstrated that MLCK peptide more potently inhibited IP~3~R when the cytosolic free Ca^2+^ concentration was increased \[[@B35]\]. Similar results were obtained with 1-8-14 peptide ([Figure 2](#F2){ref-type="fig"}F). We conclude that 1-8-14 peptide inhibits IP~3~-evoked Ca^2+^ release by binding to the IP~3~R and the inhibition is enhanced at elevated cytosolic Ca^2+^ concentrations.

Inhibition of single-channel currents through IP~3~Rs by 1-8-14 peptide
-----------------------------------------------------------------------

In patch-clamp recordings from the nuclear envelope of DT40 cells expressing rat IP~3~R1, a maximally effective concentration of IP~3~ stimulated IP~3~R activity and this was massively attenuated by the 1-8-14 peptide (3 mM) ([Figures 3](#F3){ref-type="fig"}A and [3](#F3){ref-type="fig"}B). Our results are consistent with the peptide causing a 50% decrease in the mean channel open time (τ~o~) ([Figure 3](#F3){ref-type="fig"}C). However, the overall channel activity (*NP*~o~) was so low under these conditions that we cannot reliably estimate the number of active IP~3~Rs (*N*) within each patch. We cannot therefore entirely eliminate the possibility that each patch fortuitously included several IP~3~Rs and that their clustering caused τ~o~ to fall from \~10 ms to \~5 ms as we reported previously \[[@B40]\]. An effect on τ~o~ would be unusual because most regulators of IP~3~Rs affect the duration of closed states (τ~c~) \[[@B6],[@B40]\]. The effect of the peptide on τ~o~ is not, however, sufficient to account for the \~10-fold decrease in *NP*~o~ ([Figure 3](#F3){ref-type="fig"}A), suggesting that the 1-8-14 peptide must also affect the rate of channel opening (i.e. τ~c~). Because it was impossible to determine the number of active IP~3~Rs in the presence of 1-8-14 peptide (see above), we could not reliably determine τ~c~. The single-channel conductance (γ~Cs~) was unaffected by 1-8-14 peptide: it was 214±6 pS (*n*=3) and 209±6 pS (*n*=3) for control and peptide-treated IP~3~Rs respectively ([Figure 3](#F3){ref-type="fig"}D).

![Inhibition of IP~3~R gating by 1-8-14 peptide\
(**A**) Typical recordings from excised nuclear patches stimulated with IP~3~ (10 μM) with and without 1-8-14 peptide (3 mM) in the pipette solution. The holding potential was +40 mV. The closed state is shown. (**B** and **C**) *NP*~o~ (**B**) and τ~o~ (**C**) for IP~3~R stimulated with IP~3~ alone or with 1-8-14 peptide (3 mM, +Pep). Results for IP~3~R^L60E^ are also shown. *\*P*\<0.05, *\*\*\*P*\<0.001 and *\*\*\*\*P*\<0.0001 relative to native IP~3~R without peptide. (**D**) Single-channel current (*i*)--voltage (V) relationships for the three stimulation conditions. Results in (**B**)--(**D**) are means±S.E.M. (*n*≥3).](bj2012-1034i003){#F3}

These results establish that a peptide derived from an endogenous 1-8-14 motif within the SD of the IP~3~R is similar to MLCK peptide in causing substantial and reversible inhibition of IP~3~Rs that is independent of CaM. This conclusion is consistent with our suggestion that MLCK peptide inhibits IP~3~Rs by mimicking an endogenous 1-8-14 motif, and so perhaps 'unzipping' an interdomain interaction \[[@B43]\] that is essential for activation of IP~3~Rs.

1-8-14 peptide uncouples IP~3~ binding from activation of IP~3~Rs
-----------------------------------------------------------------

Removal of the SD increases the affinity of both full-length IP~3~Rs and the NT for IP~3~ \[[@B33]\]. We \[[@B33]\] have suggested that this reflects the use of binding energy to drive conformational rearrangement of SD-IBC interfaces during the initial steps of IP~3~R activation \[[@B5],[@B44]\].

1-8-14 peptide (3 mM) increased specific binding of \[^3^H\]IP~3~ to full-length IP~3~R1. Similar results were obtained with the NT, but IP~3~ binding to the IBC was unaffected ([Figure 4](#F4){ref-type="fig"}A). The latter demonstrates that 1-8-14 peptide does not interact directly with either the IP~3~-binding site or with IP~3~. Neither the mutated (1-8-14^C^) nor scrambled (1-8-14^S^) peptide had any effect on IP~3~ binding to the NT ([Figure 4](#F4){ref-type="fig"}A). These results with IP~3~R fragments expressed in *E. coli*, which lack CaM, also further support our conclusion that the effects of 1-8-14 peptide are entirely independent of CaM.

![1-8-14 peptide directly stimulates IP~3~ binding to the NT of IP~3~R\
(**A**) Specific equilibrium binding of \[^3^H\]IP~3~ (1.5 nM) to membranes from rat cerebellum (full-length IP~3~R, FL) or to isolated NT or IBC, alone or in the presence of 3 mM of the indicated peptide. *\*P*\<0.05 and *\*\*P*\<0.01 relative to control; comparisons were performed on the raw data. (**B**) Concentration-dependent effects of 1-8-14 peptide on specific \[^3^H\]IP~3~ binding to NT in CLM with 220 nM free Ca^2+^ concentration, plotted as the increase in specific \[^3^H\]IP~3~ binding as a percentage of that evoked by the maximal concentration of peptide. Results are means±S.E.M. (*n*≥3).](bj2012-1034i004){#F4}

Comparison of the effects of 1-8-14 peptide on stimulating \[^3^H\]IP~3~ binding to the NT (EC~50~, 615 μM; pEC~50~, 3.21±0.19) ([Figure 4](#F4){ref-type="fig"}B) with its inhibitory effect on IP~3~-evoked Ca^2+^ release (IC~50~, 767 μM; pIC~50~, 3.1±0.25) ([Figure 2](#F2){ref-type="fig"}C) demonstrates that each is similarly sensitive to the peptide. These results are consistent with our hypothesis that the 1-8-14 peptide disrupts an interaction between the SD and IBC that is essential for IP~3~R activation. The peptide thereby inhibits IP~3~-evoked Ca^2+^ release ([Figure 2](#F2){ref-type="fig"}) and IP~3~R activity ([Figure 3](#F3){ref-type="fig"}) and, by uncoupling IP~3~ binding from subsequent conformational changes, it stimulates IP~3~ binding ([Figure 4](#F4){ref-type="fig"}). Subsequent experiments used mutagenesis of residues within the endogenous 1-8-14 motif to test this hypothesis further.

Mutations within the endogenous 1-8-14 sequence increase IP~3~-binding affinity
-------------------------------------------------------------------------------

If, as we suggest, the 1-8-14 peptide disrupts an essential interaction between the endogenous 1-8-14 sequence and another domain within the NT, we might expect mutation of appropriate residues in the SD to both disrupt IP~3~R activation and increase IP~3~-binding affinity. We tested the latter prediction by examining IP~3~ binding to the NT in which each of the critical (1, 8 and 14) hydrophobic/aromatic residues that are important for Ca^2+^--CaM binding to 1-8-14 motifs \[[@B45]\] was replaced with a charged hydrophilic residue (glutamate). The same hydrophobic residues are essential for MLCK \[[@B35]\] and 1-8-14 ([Figure 2](#F2){ref-type="fig"}C) peptides to disrupt IP~3~R activation.

NTs of IP~3~R1 with point mutations in positions equivalent to the 1- (F53E), 8- (L60E) or 14-position (Y66E) of the endogenous 1-8-14 motif ([Figure 1](#F1){ref-type="fig"}A) were expressed in *E. coli*. Expression levels of the NT and its mutants were not identical ([Figure 5](#F5){ref-type="fig"}A), but they were each sufficient to allow the affinity for IP~3~ and the effects of peptides to be determined after cleavage of the His~6~ tag, but without further purification \[[@B33]\]. As expected, IP~3~ bound to the IBC with greater affinity (17-fold) than to the NT ([Figure 5](#F5){ref-type="fig"}B) \[[@B33],[@B46],[@B47]\], consistent with our suggestion that, in the absence of the SD, less binding energy is diverted into conformational changes \[[@B33]\]. Mutation of critical residues within the endogenous 1-8-14 motif significantly increased the affinity of the NT for IP~3~ ([Figure 5](#F5){ref-type="fig"}B and [Table 1](#T1){ref-type="table"}), although none was as effective as complete removal of the SD. This is consistent with our observation that neither the 1-8-14 ([Figure 2](#F2){ref-type="fig"}) nor MLCK \[[@B35]\] peptide entirely inhibits IP~3~-evoked Ca^2+^ release, whereas removal of the SD totally uncouples IP~3~ binding from IP~3~R activation \[[@B48]\]. Although maximally effective concentrations of MLCK (100 μM) or 1-8-14 (3 mM) peptides similarly increased IP~3~ binding to the NT, neither peptide had any effect on \[^3^H\]IP~3~ binding to the NT with mutations in any of the critical 1-8-14 residues ([Figures 5](#F5){ref-type="fig"}C and [5](#F5){ref-type="fig"}D). Mutation of a residue immediately preceding the critical 1-position of the 1-8-14 motif (K52E), which did not increase the affinity of IP~3~ for the NT (Supplementary Figure S2A at <http://www.BiochemJ.org/bj/449/bj4490039add.htm>), had no effect on the responses to MLCK or 1-8-14 peptides ([Figures 5](#F5){ref-type="fig"}C and [5](#F5){ref-type="fig"}D) and neither did it affect IP~3~-evoked Ca^2+^ release \[[@B33]\] (Supplementary Figure S2B). These results establish that mutation of critical residues within the endogenous 1-8-14 motif selectively increases IP~3~-binding affinity and these effects are non-additive with those of either MLCK or 1-8-14 peptide.

![Mutations within the 1-8-14 motif mimic the effect of 1-8-14 peptide on IP~3~ binding\
(**A**) Western blot (typical of three independent experiments) with an anti-His~6~ antibody of lysates (5 μg of protein/lane) from bacteria expressing NT with the indicated mutations. The 80 kDa molecular-mass marker is shown. (**B**) Concentration-dependent effect of IP~3~ on specific \[^3^H\]IP~3~ binding to the IBC, NT and mutated NT. (**C** and **D**) Effects of MLCK peptide (**C**, 100 μM) and 1-8-14 peptide (**D**, 3 mM) on specific binding of \[^3^H\]IP~3~ (1.5 nM) to the NT and the indicated mutants (each expressed as a percentage of the control). (**E**) Specific binding of \[^3^H\]IP~3~ (1.5 nM) to the IBC, NT and mutated NT in the presence of the indicated concentrations of heparin. (**F**) Summary results from experiments similar to those in (**E**) showing the *K*~d~ for IP~3~ and heparin binding to the IBC, NT and mutated NT. Results in (**B**)--(**F**) are means±S.E.M. (*n*≥3). *\*P*\<0.05, *\*\*P*\<0.01 and *\*\*\*P*\<0.001 relative to control; comparisons were performed on the raw data.](bj2012-1034i005){#F5}

###### Binding of IP~3~ and heparin to N-terminal fragments of IP~3~R1

Equilibrium competition binding using \[^3^H\]IP~3~ was used to measure the p*K*~d~ of IP~3~ and heparin for the N-terminal fragments of IP~3~R1. Affinities for ligands are also shown expressed as fold increase relative to wild-type NT (i.e. *K*~d~^NT^/*K*~d~^mutant^). Results are means±S.E.M. (*n*≥3). \**P*\<0.05, \*\**P*\<0.01 and \*\*\**P*\<0.001 relative to NT.

  Fragment   p*K*~d~, /M IP~3~ (*K*~d~, nM)   Affinity relative to NT   p*K*~d~, /g/ml heparin (*K*~d~, ng/ml)   Affinity relative to NT
  ---------- -------------------------------- ------------------------- ---------------------------------------- -------------------------
  NT         7.40±0.11 (40.0)                 1                         6.62±0.06 (239)                          1
  F53E       7.97±0.05\*\* (10.8)             4                         6.92±0.06\*\* (120)                      2
  L60E       7.84±0.08\* (14.5)               3                         6.70±0.04 (200)                          1.2
  Y66E       7.64±0.04 (22.8)                 2                         6.77±0.03 (171)                          1.4
  IBC        8.62±0.05\*\*\* (2.4)            17                        6.93±0.04\*\* (117)                      2.0

Mutations within the 1-8-14 motif selectively increase agonist affinity
-----------------------------------------------------------------------

Our hypothesis is that the apparent affinity of agonists (such as IP~3~) for native IP~3~Rs is reduced because some of their binding energy is diverted into the conformational changes that activate the IP~3~R \[[@B33]\]. Antagonists, because they need not evoke the rearrangement of the IBC and SD that initiates IP~3~R activation, may be less affected by disruption of these interactions. We therefore examined the effects of the SD and of point mutations within the endogenous 1-8-14 sequence on binding to the NT of heparin, a competitive antagonist of IP~3~ \[[@B49]\]. The results demonstrate that, whereas removal of the SD increased the affinity of the NT for IP~3~ 17-fold, it caused only a 2-fold increase in the affinity for heparin. Point mutations within the endogenous 1-8-14 motif also caused larger increases in the affinity for IP~3~ than for heparin ([Figures 5](#F5){ref-type="fig"}E and [5](#F5){ref-type="fig"}F, and [Table 1](#T1){ref-type="table"}). These results are important because they demonstrate that the effects of the SD and of mutations within the 1-8-14 sequence on ligand binding are specific for an agonist of the IP~3~R. They thereby demonstrate the importance of the 1-8-14 motif in specifically mediating activation of IP~3~Rs.

Mutations within the endogenous 1-8-14 motif uncouple IP~3~ binding from gating of IP~3~Rs
------------------------------------------------------------------------------------------

It proved difficult to establish stable DT40 cell lines expressing rat IP~3~R1 in which critical residues within the 1-8-14 motif were mutated, but we succeeded with two mutants ([Figure 6](#F6){ref-type="fig"}A). The first (IP~3~R^L60E^) is mutated at the 8-position of the 1-8-14 motif and the second has mutations at both the 1- (F53E) and 14-positions (Y66E) (IP~3~R^FY^). As expected, a maximally effective concentration of IP~3~ (10 μM) failed to stimulate Ca^2+^ release from permeabilized DT40 cells lacking IP~3~R (DT40-KO cells) \[[@B37],[@B40]\], but it caused release of 81±1% of the Ca^2+^ stores of DT40-IP~3~R1 cells ([Figures 6](#F6){ref-type="fig"}B and [6](#F6){ref-type="fig"}C). In the cell lines expressing IP~3~R with a mutated 1-8-14 motif, there was barely detectable Ca^2+^ release that was not significantly different from that observed in DT40-KO cells ([Figures 6](#F6){ref-type="fig"}B and [6](#F6){ref-type="fig"}C). ATP-dependent Ca^2+^ uptake into the ER was similar for each cell line ([Figure 6](#F6){ref-type="fig"}C). We were concerned that the lower level of expression of mutant IP~3~R relative to wild-type (\~30--50%, [Figure 6](#F6){ref-type="fig"}A) might have contributed to the lack of detectable IP~3~-evoked Ca^2+^ release. However, in another stable DT40 cell line where the IP~3~-binding site was mutated (R568Q), causing a \~10-fold decrease in IP~3~ affinity \[[@B50]\], IP~3~R expression (\~15% of wild-type) was less than half that of the cell lines with mutations in the 1-8-14 motif ([Figure 6](#F6){ref-type="fig"}A). Nevertheless, IP~3~ caused a readily detectable release of Ca^2+^ from the intracellular stores of DT40-IP~3~R^R568Q^ cells (49±2% of that detected in DT40-IP~3~R1 cells) ([Figures 6](#F6){ref-type="fig"}B and [6](#F6){ref-type="fig"}C). We conclude that the lack of detectable Ca^2+^ release in cells expressing IP~3~R with a mutant 1-8-14 motif is not attributable to reduced IP~3~R expression. Neither is it likely that the lack of response to IP~3~ from mutant IP~3~R reflects a more global disruption of IP~3~R structure because each of the full-length mutant IP~3~Rs bound IP~3~, although, as predicted, addition of MLCK peptide increased IP~3~ binding to only the wild-type IP~3~R ([Figure 6](#F6){ref-type="fig"}D). Furthermore, DT40 cells expressing IP~3~R1 with a mutation in an adjacent residue (DT40-IP~3~R1^K52E^) responded normally to IP~3~ \[[@B33]\] (Supplementary Figure S2B). These results are consistent with the suggestion that mutations within the endogenous 1-8-14 motif mimic addition of exogenous MLCK peptide by uncoupling IP~3~ binding from the conformational changes that lead to opening of the IP~3~R pore. Single-channel analyses provide further support for this conclusion.

![The endogenous 1-8-14 motif is essential for activation of IP~3~R\
(**A**) Expression of IP~3~R1 in DT40 cells stably expressing each of the indicated mutants. Each lane was loaded with 4×10^3^ cells and probed with antisera to IP~3~R1 (upper panel) or β-adaptin (lower panel). The R568Q mutant (which reduces the affinity of the IP~3~R for IP~3~) \[[@B50]\] is shown because it provides a control for functional assays of cells expressing IP~3~R at low density. Molecular-mass markers are shown on the right. The Western blot is typical of three independent experiments. The lower panel shows summary results (means±S.E.M., *n*=3), where IP~3~R expression was calculated from blots that included DT40-IP~3~R1 membranes in which levels of expression were established by equilibrium competition \[^3^H\]IP~3~ binding. (**B**) Typical responses to IP~3~ (10 μM) from DT40 cells lacking IP~3~R (KO) or expressing wild-type IP~3~R1 or IP~3~R with the indicated mutations (see the text for details). (**C**) Summary results show the Ca^2+^ content of the loaded stores (●) and the Ca^2+^ released by IP~3~ (histograms) for each of the indicated cell lines. (**D**) Specific \[^3^H\]IP~3~ binding (1.5 nM) to full-length IP~3~R (FL) with the indicated mutations (L60E or FY, see the text for details) in permeabilized DT40 cells alone or in the presence of 100 μM MLCK peptide. Results in (**C**) and (**D**) are means±S.E.M. (*n*≥3). (**E**) Typical records from active excised nuclear patches of DT40 cells expressing IP~3~R1 or IP~3~R1^L60E^ stimulated with IP~3~ (10 μM). The holding potential was +40 mV. C denotes the closed state. Summary data are provided in [Figures 3](#F3){ref-type="fig"}(B)--[3](#F3){ref-type="fig"}(D). *\*\*P*\<0.01, *\*\*\*P*\<0.001 and *\*\*\*\*P*\<0.0001 relative to IP~3~R1 (**A** and **C**) or control (**D**).](bj2012-1034i006){#F6}

Yamazaki et al. \[[@B51]\] reported recently the functional effects of mutations within IP~3~R including some within the 1-8-14 motif (F53D and Y66A). We note, however, that some of their mutations, e.g. Y167A, which is clearly implicated in IP~3~R activation, abolished IP~3~-evoked Ca^2+^ release from microsomes without affecting Ca^2+^ signals evoked by activation of the BCR (B-cell receptor) in intact cells. This unexplained disparity casts some doubt over whether in these assays responses from intact cells faithfully report the activity of IP~3~R. In DT40 cells expressing an IP~3~R with five mutations that included Y66A (the 14-position of the 1-8-14 motif), activation of the BCR evoked a Ca^2+^ signal, suggesting that the mutant IP~3~R was functional \[[@B51]\]. However, in this IP~3~R, the mutant had one hydrophobic residue replaced by another and this might not radically affect the behaviour of the 1-8-14 motif. In preliminary analyses of cells expressing IP~3~Rs in which the first position of the 1-8-14 motif was mutated (F53D), Ca^2+^ signals were also observed after activation of the BCR \[[@B51]\]. This may reflect a limitation of the BCR-based assay (see above) or it may provide evidence for a lesser role of the 1-position in the 1-8-14 motif. We have not succeeded in establishing a DT40 cell line expressing IP~3~Rs with only this mutation, although our results do clearly show that IP~3~Rs with mutations in both the 1- and 14-positions (IP~3~R^FY^) are barely responsive to IP~3~ ([Figure 6](#F6){ref-type="fig"}).

Mutation of the endogenous 1-8-14 motif attenuates IP~3~R gating without affecting single-channel conductance
-------------------------------------------------------------------------------------------------------------

In keeping with the reduced expression of IP~3~R^L60E^ in DT40 cells ([Figure 6](#F6){ref-type="fig"}A), the frequency with which functional IP~3~Rs were detected in excised nuclear patches was much lower for nuclei from paired experiments with DT40-IP~3~R1^L60E^ cells (three of 48 patches) than from DT40-IP~3~R1 cells (five of 13 patches). In parallel analyses, functional IP~3~Rs were never detected in DT40-KO cells (none of 30 patches). The single-channel conductances (γ~Cs~) of the mutant IP~3~R^L60E^ (209±8 pS) and normal IP~3~R (214±6 pS) were indistinguishable ([Figure 3](#F3){ref-type="fig"}D), but *NP*~o~ was massively decreased in the mutant ([Figures 3](#F3){ref-type="fig"}B and [6](#F6){ref-type="fig"}E). Our interpretation of the latter is, as we described in our analyses of the 1-8-14 peptide, limited by our inability, when *NP*~o~ is so low for IP~3~R1^L60E^, to estimate reliably the number of active IP~3~R within a patch. Nevertheless, it is clear that the major effect on single-channel behaviour of mutating the endogenous 1-8-14 motif of IP~3~R1 ([Figures 3](#F3){ref-type="fig"}B--[3](#F3){ref-type="fig"}D and [6](#F6){ref-type="fig"}E) and of adding 1-8-14 peptide to normal IP~3~R1 ([Figure 3](#F3){ref-type="fig"}) is similar: both decrease *NP*~o~ without affecting γ~Cs~. These results establish that mutations in the endogenous 1-8-14 motif or addition of 1-8-14 peptide uncouple ligand binding from channel gating without compromising the behaviour of the pore.

Conclusions: interactions between endogenous 1-8-14 and CaM-like motifs mediate activation of IP~3~Rs
-----------------------------------------------------------------------------------------------------

CaM \[[@B22]\] or related EF-hand-containing proteins \[[@B14],[@B25]\], peptides that comprise 1-8-14 CaM-binding motifs \[[@B35],[@B36]\] ([Figures 2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"}) or disruption of a conserved endogenous 1-8-14-like motif within the SD of IP~3~Rs inhibit IP~3~-evoked Ca^2+^ release ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}) by massively reducing *NP*~o~ of IP~3~R ([Figures 3](#F3){ref-type="fig"} and [6](#F6){ref-type="fig"}E). We conclude that an endogenous 1-8-14 motif within the SD ([Figure 1](#F1){ref-type="fig"}) is essential for IP~3~R activation. Where it has been examined, the inhibitory proteins or peptides are more potent when Ca^2+^ is bound to the IP~3~R \[[@B26],[@B35]\] ([Figure 2](#F2){ref-type="fig"}F). We therefore speculate that the endogenous 1-8-14 motif may interact with an unidentified domain that includes an EF-hand-like structure and that these interactions might be related to Ca^2+^ regulation of IP~3~R ([Figure 7](#F7){ref-type="fig"}). We suggest that competing peptides (CaM-like or 1-8-14 motifs) or mutagenesis of the endogenous 1-8-14 motif inhibit IP~3~Rs by disrupting this essential interaction in a manner similar to the 'unzipping' of interdomain interactions in RyRs \[[@B32],[@B43],[@B52]\]. The scheme is appealing because IP~3~ regulates binding of Ca^2+^ to IP~3~Rs and thereby leads to channel gating \[[@B34],[@B53]\]. The identity of this Ca^2+^-binding site is unknown. It is, however, clear that Ca^2+^ regulates IP~3~ binding to the NT only when the SD is present \[[@B42]\], suggesting that a Ca^2+^-binding site within the NT may be regulated by interactions between the SD and IBC. One possibility is that an endogenous EF-hand-like structure might provide the Ca^2+^-binding site and that its interaction with the 1-8-14 motif links IP~3~ and Ca^2+^ binding ([Figure 7](#F7){ref-type="fig"}A). Bioinformatic analyses had suggested the presence of two possible EF-hand-like structures within the IBC \[[@B9],[@B54]\], but neither is evident in high-resolution structures of the IBC \[[@B55]\] and NT \[[@B5],[@B56]\]. Neither have we succeeded in identifying a complementary partner of the 1-8-14 motif. Another possibility is suggested by comparison of the structures of the NT with and without IP~3~ bound \[[@B5],[@B56]\], which reveal that Phe^53^ (the first hydrophobic residue of the 1-8-14 motif) and Phe^223^ are closely apposed (\~3.9 Å; 1 Å=0.1 nm), but they move apart (\~5.3 Å) when IP~3~ binds ([Figure 7](#F7){ref-type="fig"}B). A β-sheet links Phe^223^ to Glu^246^, and the movement of Phe^223^ is associated with a repositioning of an acidic residue in the β-domain of the IBC (Glu^246^). This brings Glu^246^ closer to three other acidic residues (Glu^425^, Asp^426^ and Glu^428^). The rearrangement is interesting because these four residues have been proposed to form a Ca^2+^-binding site (Ca-I) \[[@B55]\]. Furthermore, a peptide (residues 378--450) that includes most of these residues binds Ca^2+^, and the binding is abolished by mutation of the acidic residues \[[@B42]\]. A second possibility is therefore that IP~3~-evoked movement of the critical 1-8-14 motif contributes to formation of an effective Ca^2+^-binding site within the IBC by bringing a fourth acidic residue into appropriate association with three others.

![Activation of IP~3~Rs requires an endogenous 1-8-14 motif\
IP~3~ binding to the IBC initiates conformational changes that pass via the SD and lead, via regulation of Ca^2+^ binding to the IP~3~R, to opening of the pore \[[@B33]\]. (**A**) An endogenous 1-8-14 motif within the SD is essential for IP~3~R activation. We speculate (upper panel) that interaction of this CaM-binding motif (red, conserved hydrophobic residues in dark blue) with an endogenous, but presently unknown, CaM-like structure (pale blue) within the NT may link IP~3~ binding to Ca^2+^ binding. (**B**) Another possibility is that IP~3~ binding rearranges the 1-8-14 motif and so repositions a critical acidic residue (Glu^246^) that may then contribute to a Ca^2+^-binding site (Ca-1) \[[@B55]\]. The NT without IP~3~ bound (PDB code 3UJ0) \[[@B5]\] is shown with the IBC in grey and the SD in green to highlight Phe^53^ (within the 1-8-14 motif) and Phe^223^ to which it is closely apposed (yellow box), residues proposed to form the Ca-1 site (pink box) and the β-sheet that links Phe^223^ to Glu^246^ (cyan box). The expanded views (each rotated to show key movements) show the critical residues and the linking β-sheet before (green) and after IP~3~ binding (blue, PDB code 3UJ4). The carboxy oxygen atoms in Glu^246^ are shown in magenta. We speculate that separation of Phe^53^ and Phe^223^ when IP~3~ binds is associated with twisting of the linking β-sheet and movement of Glu^246^ towards three other acidic residues (Glu^425^, Asp^426^ and Glu^428^) and that they may then together form an effective Ca^2+^-binding site.](bj2012-1034i007){#F7}

We conclude that a conserved 1-8-14 motif within the SD is essential for IP~3~R activation and speculate that its interaction with either an endogenous CaM-like motif or acidic residues within the IBC may link IP~3~ and Ca^2+^ binding. Inhibition of IP~3~R by CaM and related proteins probably results from disruption of this essential interaction.
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